FDA.reportPublic FDA data

benzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral Gel

RxCUI
1006079
RxNorm name
benzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral Gel
Display name
Benzocaine/Menthol (Oral Gel)
Full name
benzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral Gel
Term type
SCD
Status
Active
Strength
20-2%
Dose form
Gel
Route
Oral Gel
Updated
2026-06-05 07:03:37

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092010
Active start
092010
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
benzocaine0.2 MG / 1 MGbenzocainebenzocaine
menthol0.02 MG / 1 MGmentholmenthol

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Gel346169

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
benzocaine1399
menthol6750

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRbenzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral GelNAMES
RxNorm Namebenzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral GelNAMES
RxNorm Synonymbenzocaine 20 % / menthol 2 % Mucous Membrane Topical GelNAMES
TTYSCDATTRIBUTES
SPL_SET_ID078fcdab-38a1-4a9a-bdd3-e17446591ea8CODES
RxCUI1006079CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
10157-2127-110157-2127Kanka Triple Action BENZOCAINE and MENTHOL, UNSPECIFIED FORMBlistex Inc.M022

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M02210157-2127Kanka Triple Action BENZOCAINE and MENTHOL, UNSPECIFIED FORMOTC MONOGRAPH DRUGBlistex Inc.

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
10157212701rxnav_ndcsyes
10310037770rxnav_historical_indirect

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
078fcdab-38a1-4a9a-bdd3-e17446591ea8benzocaine 20 % / menthol 2 % Mucous Membrane Topical GelSY1Kanka ® Triple Action Gel20250109
078fcdab-38a1-4a9a-bdd3-e17446591ea8benzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral GelSCD1Kanka ® Triple Action Gel20250109
078fcdab-38a1-4a9a-bdd3-e17446591ea8benzocaine 20 % / menthol 2 % Oral GelPSN1Kanka ® Triple Action Gel20250109

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
078fcdab-38a1-4a9a-bdd3-e17446591ea8Kanka ® Triple Action GelBlistex Inc.20250109

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04ABAnesthetics for topical useATC1-4benzocaine
ATCR02ADAnesthetics, localATC1-4benzocaine
ATCN01BAEsters of aminobenzoic acidATC1-4benzocaine
ATCC05ADLocal anestheticsATC1-4benzocaine
FDASPLN0000185508Standardized Chemical AllergenEPChas_epcbenzocaine
FDASPLN0000184306Cell-mediated ImmunityPEhas_pebenzocaine
FDASPLN0000175629Increased Histamine ReleasePEhas_pebenzocaine
MEDRTD001566BenzocaineCHEMhas_ingredientbenzocaine
MEDRTD008610MentholCHEMhas_ingredientmenthol
MEDRTD001424Bacterial InfectionsDISEASEci_withbenzocaine
MEDRTD002056BurnsDISEASEmay_treatbenzocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withmenthol
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzocaine
MEDRTD004433EaracheDISEASEmay_treatbenzocaine
MEDRTD005401Fissure in AnoDISEASEmay_treatbenzocaine
MEDRTD006484HemorrhoidsDISEASEmay_treatbenzocaine
MEDRTD006561Herpes SimplexDISEASEmay_treatbenzocaine
MEDRTD019226Oral UlcerDISEASEmay_treatbenzocaine
MEDRTD010032Otitis ExternaDISEASEmay_treatbenzocaine
MEDRTD010033Otitis MediaDISEASEmay_treatbenzocaine
MEDRTD010146PainDISEASEmay_preventbenzocaine
MEDRTD010146PainDISEASEmay_treatmenthol
MEDRTD011537PruritusDISEASEmay_treatbenzocaine
MEDRTD012871Skin DiseasesDISEASEmay_treatmenthol
MEDRTD014098ToothacheDISEASEmay_treatbenzocaine
MEDRTN0000000069Calcium Channel AntagonistsMOAhas_moamenthol
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moabenzocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pebenzocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pementhol

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.2 MG/MG / 0.02 MG/MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSCD
CODESRxCUI1006079
CODESSPL_SET_ID078fcdab-38a1-4a9a-bdd3-e17446591ea8
NAMESPrescribable Synonymbenzocaine 20 % / menthol 2 % Oral Gel
NAMESRXNAV_STRbenzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral Gel
NAMESRxNorm Namebenzocaine 0.2 MG/MG / menthol 0.02 MG/MG Oral Gel
NAMESRxNorm Synonymbenzocaine 20 % / menthol 2 % Mucous Membrane Topical Gel
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels